Literature DB >> 24411325

Use of concentric Solitaire stent to anchor Pipeline flow diverter constructs in treatment of shallow cervical carotid dissecting pseudoaneurysms.

Jason P Rahal1, Venkata S Dandamudi1, Robert S Heller1, Mina G Safain1, Adel M Malek2.   

Abstract

The flow-diverting Pipeline Embolization Device (PED; ev3 Neurovascular, Irvine, CA, USA) provides proven flow diversion for intracranial wide-necked and fusiform aneurysms. The tendency of the PED to migrate and foreshorten when its size is mismatched with the parent vessel makes its use more difficult for cervical carotid pseudoaneurysms, as the parent vessel regains its luminal diameter during the healing phase, and because of its mobility during head movement. We present a novel technique of using a Solitaire detachable stent (ev3 Neurovascular) to anchor PED constructs to mitigate these shortcomings. Two patients with shallow and broad-necked cervical carotid pseudoaneurysms with underlying parent vessel stenosis deemed poor candidates for conventional stent-supported coiling were treated using tandem overlapping PED centered over the neck of the pseudoaneurysm and a Solitaire concentric anchor was deployed to overlap distally and proximally. As predicted, both patients revealed carotid luminal gain after aneurysm thrombosis with attendant migration (3.8 and 2.8mm) and expansion of the PED construct (14% and 7.8%) which remained constrained within the Solitaire anchoring device with persistent luminal patency and no evidence of endoleak at follow-up (3 and 5 months). The use of a concentric anchoring stent can mitigate the inherent tendency of the braided flow-diverting PED to migrate and foreshorten as the target vessel heals upon pseudoaneurysm thrombosis. This novel technique opens the possibility of using PED to treat shallow or fusiform lesions in mobile cervical arteries previously relegated to stent-supported coiling or surgical reconstruction.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Carotid dissection; Pipeline stent; Pseudoaneurysm; Solitaire stent

Mesh:

Year:  2013        PMID: 24411325     DOI: 10.1016/j.jocn.2013.10.017

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  7 in total

1.  Endovascular techniques for achievement of better flow diverter wall apposition.

Authors:  Anna L Kühn; Katyucia de Macedo Rodrigues; Ajay K Wakhloo; Ajit S Puri
Journal:  Interv Neuroradiol       Date:  2018-11-28       Impact factor: 1.610

2.  The Exchange-Free Technique: A Novel Technique for Enhancing Surpass Flow Diverter Placement.

Authors:  Osman Ocal; Anıl Arat
Journal:  Asian J Neurosurg       Date:  2020-08-28

3.  Placement of a Stent within a Flow Diverter Improves Aneurysm Occlusion Rates.

Authors:  O Ocal; A Peker; S Balci; A Arat
Journal:  AJNR Am J Neuroradiol       Date:  2019-10-03       Impact factor: 3.825

4.  Use of self-expanding stents for better intracranial flow diverter wall apposition.

Authors:  Anna Luisa Kühn; Ajay K Wakhloo; Matthew J Gounis; Peter Kan; Katyucia de Macedo Rodrigues; J Diego Lozano; Miklos G Marosfoi; Mary Perras; Christopher Brooks; Mary C Howk; David E Rex; Francesco Massari; Ajit S Puri
Journal:  Interv Neuroradiol       Date:  2016-12-12       Impact factor: 1.610

5.  Pipeline embolization device as primary treatment for cervical internal carotid artery pseudoaneurysms.

Authors:  Arthur Wang; Justin Santarelli; Michael F Stiefel
Journal:  Surg Neurol Int       Date:  2017-01-19

6.  Endovascular management of internal carotid artery dissection with associated aneurysm using a multilayer flow modulator.

Authors:  Orlando López; Carlos Piñana; Laura Ludovica Gramegna; José Rodríguez; David Hernández; Alejandro Tomasello
Journal:  J Vasc Surg Cases Innov Tech       Date:  2020-05-11

7.  Anchoring Pipeline Flow Diverter Construct in the Treatment of Traumatic Distal Cervical Carotid Artery Injury.

Authors:  Krishna Amuluru; Fawaz Al-Mufti; William Roth; Charles J Prestigiacomo; Chirag D Gandhi
Journal:  Interv Neurol       Date:  2017-04-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.